Cryoport Past Earnings Performance

Past criteria checks 0/6

Cryoport's earnings have been declining at an average annual rate of -16.5%, while the Life Sciences industry saw earnings growing at 5.5% annually. Revenues have been growing at an average rate of 24.4% per year.

Key information

-16.5%

Earnings growth rate

-13.1%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate24.4%
Return on equity-28.6%
Net Margin-53.7%
Last Earnings Update31 Dec 2024

Recent past performance updates

Recent updates

Cryoport, Inc. (NASDAQ:CYRX) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 06
Cryoport, Inc. (NASDAQ:CYRX) Just Reported Earnings, And Analysts Cut Their Target Price

Market Cool On Cryoport, Inc.'s (NASDAQ:CYRX) Revenues Pushing Shares 25% Lower

Feb 22
Market Cool On Cryoport, Inc.'s (NASDAQ:CYRX) Revenues Pushing Shares 25% Lower

Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)

Dec 03
Investors Continue Waiting On Sidelines For Cryoport, Inc. (NASDAQ:CYRX)

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Nov 06
Is Cryoport (NASDAQ:CYRX) A Risky Investment?

The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More

Aug 09
The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Jul 22
Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch

Jun 25
Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch

Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk

Apr 15
Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk

Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 15
Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Cryoport Tanks On Chilling Results And Bad Decisions

Mar 14

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Mar 10
Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)

Jan 15
Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Oct 06
Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term

Jul 23
Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term

Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity

Jul 12
Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Jun 13
Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price

Mar 06
Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price

Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially

Nov 07
Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Sep 23
Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Cryoport: A Rare Investing Opportunity

Sep 22

Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services

Sep 08

Cryoport: Rapid Growth Is Great, But Shares Look Overpriced

Jul 30

Cryoport: To Resume Aggressive Growth

May 11

Revenue & Expenses Breakdown

How Cryoport makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:CYRX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 24228-12314818
30 Sep 24226-16614718
30 Jun 24226-18114919
31 Mar 24225-12114619
31 Dec 23233-10814118
30 Sep 23236-5513418
30 Jun 23241-4712817
31 Mar 23248-3812316
31 Dec 22237-4512016
30 Sep 22233-29610915
30 Jun 22230-29710315
31 Mar 22222-2939816
31 Dec 21223-2849817
30 Sep 21215-769316
30 Jun 21169-787715
31 Mar 21122-776112
31 Dec 2079-75479
30 Sep 2040-22287
30 Jun 2038-23366
31 Mar 2037-20335
31 Dec 1934-18314
30 Sep 1930-20313
30 Jun 1926-9202
31 Mar 1922-9182
31 Dec 1820-10172
30 Sep 1817-10162
30 Jun 1815-9152
31 Mar 1813-9141
31 Dec 1712-8131
30 Sep 1711-10121
30 Jun 1710-10111
31 Mar 179-12111
31 Dec 168-13111
30 Sep 167-12111
30 Jun 166-12111
31 Mar 166-15100
31 Dec 156-1690
30 Sep 155-1580
30 Jun 154-1670
31 Mar 154-1260
31 Dec 144-1060
30 Sep 143-1060
30 Jun 143-2150
31 Mar 143-2050

Quality Earnings: CYRX is currently unprofitable.

Growing Profit Margin: CYRX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CYRX is unprofitable, and losses have increased over the past 5 years at a rate of 16.5% per year.

Accelerating Growth: Unable to compare CYRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CYRX is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-3.9%).


Return on Equity

High ROE: CYRX has a negative Return on Equity (-28.55%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/16 18:20
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cryoport, Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan ZhiB. Riley Securities, Inc.
Andrew D'SilvaB. Riley Securities, Inc.
David LarsenBTIG